Resmetirom

CAS: 920509-32-6

Ref. 3D-VLB50932

Produktinformation

• Name: Resmetirom

Beschreibung

Resmetirom, also known as MGL-3196, is a promising drug for the treatment of hyperlipidemia and nonalcoholic steatohepatitis (NASH)(now known as metabolic dysfunction-associated steatohepatitis (MASH). It is an orally active, liver-directed, selective thyroid hormone receptor-beta agonist. Resmetirom works by targeting the thyroid hormone receptor-beta to regulate hepatic triglyceride and cholesterol metabolism, thereby reducing hepatic fat content. In clinical trials, resmetirom has shown significant reductions in liver fat content in patients with NASH without major side effects. Additionally, resmetirom has been found to improve atherogenic dyslipidemia associated with NASH by positively impacting triglyceride and LDL cholesterol levels.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 435.22 g/mol
• Formel: C₁₇H₁₂Cl₂N₆O₄
• Reinheit: (%) Min. 99%